Related references
Note: Only part of the references are listed.MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Martin Eklund et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Reconsidering Prostate Cancer Mortality - The Future of PSA Screening
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Evan Kovac et al.
JAMA NETWORK OPEN (2020)
Prostate-Specific Antigen-Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force
Joshua J. Fenton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer
Tobias Nordstrom et al.
EUROPEAN UROLOGY (2015)
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Henrik Gronberg et al.
LANCET ONCOLOGY (2015)
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
J. Athene Lane et al.
LANCET ONCOLOGY (2014)
Share Paper
